1548 — Genscript Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Genscript Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	771	1,403	1,463	1,928	621
Net Total Accounts Receivable
Net Total Receivables	166	167	171	300	136
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	993	1,639	1,765	2,353	835
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	385	505	647	751	603
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,447	2,234	2,546	3,387	5,278
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	328	413	546	495	307
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	546	1,188	1,536	1,996	957
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	902	1,046	1,011	1,391	4,321
Total Liabilities & Shareholders' Equity	1,447	2,234	2,546	3,387	5,278
Total Common Shares Outstanding